ArticleBlood and lymphatic cancer : targets and therapy2025
Optimizing Timing and Preparation for Allogeneic Hematopoietic Stem Cell Transplantation in Higher-Risk Myelodysplastic Syndromes.
Liangquan Geng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.